Compounds in coffee found to fight off Parkinson’s and

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 dw #9351
115
Compounds in coffee found to fight off Parkinson’s and Lewy body dementia

Hey I am good to go, lol

https://www.naturalnews.com/2019-03-11-compou...nsons.html

Good news for coffee drinkers: U.S. researchers have found two compounds in coffee — caffeine and EHT — work together to prevent Parkinson’s and Lewy body dementia. Recently published in the journal Proceedings of the National Academy of Sciences, the findings suggest that these compounds may potentially be used as a natural way to slow brain degeneration.

Earlier studies have shown that coffee consumption may lower the risk of developing Parkinson’s disease, and caffeine is generally known to be the protective agent. However, coffee beans have over a thousand other compounds that are less well-known. Therefore, the researchers of the current study explored other compounds in coffee beans; they focused on EHT (Eicosanoyl-5-hydroxytryptamide), which is a fatty acid derivative of the neurotransmitter serotonin found in the waxy coating of coffee beans. In an animal trial, they found that this compound protects the brains of mice against abnormal protein accumulation that is linked to Parkinson’s disease and Lewy body dementia. (Related: Coffee makes your brain younger: Research shows that by normalizing stress hormones, coffee reverses memory deficits.)

“EHT is a compound found in various types of coffee but the amount varies. It is important that the appropriate amount and ratio be determined so people don’t over-caffeinate themselves, as that can have negative health consequences,” said M. Maral Mouradian, lead author of the study and director of the Rutgers Robert Wood Johnson Medical School Institute for Neurological Therapeutics.

For the current study, U.S. researchers sought to determine whether EHT could work together with caffeine for even greater brain protection. In conducting the study, they gave mice small doses of caffeine, EHT, or both. The results showed that caffeine or EHT alone was not effective. However, when taken together, EHT and caffeine enhanced the activity of a catalyst that helps to inhibit the buildup of harmful proteins in the brain. This indicates that EHT and caffeine, in combination, has the potential to slow or stop the progression of Parkinson’s disease and Lewy body dementia.

These findings are important because current treatments only address the symptoms of Parkinson’s disease but do not protect against brain degeneration. Today, about one million people in the U.S. are living with Parkinson’s disease and suffer from its symptoms such as shaking, stiffness, and difficulty with walking, balance, and coordination. On the other hand, Lewy body dementia is one of the most common forms of dementia that affects over one million people in the U.S. This disease impairs behavior, mood, movement, and thinking.

Other compounds in coffee that are beneficial for your health
As mentioned earlier, coffee beans contain over a thousand compounds other than caffeine, and many of these are antioxidants. Antioxidants combat the damage caused by free radicals in your cells, contributing to disease prevention. These include:

Cafestol and kahweol: These compounds are present in coffee’s natural oil and can be found in high amounts in unfiltered coffee. They have been shown to protect the liver and ward off cancer. However, high consumption of these may increase low-density lipoprotein (LDL) cholesterol.
Chlorogenic acids (CGAs): CGAs are polyphenol antioxidants that may be beneficial for blood sugar metabolism and high blood pressure — both of which are associated with the risk of age-related mental decline.
Trigonelline: Trigonelline is an alkaloid compound that is unstable at high heat. Moreover, during roasting, it forms niacin or vitamin B3. This compound also has antibacterial properties that may prevent bacterial growth and protect against dental cavities.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OUTFRONT Media Gears Up for Q3 2026 Earnings Reveal

Updated Category News Views 0

OUTFRONT Media’s Earnings Drumroll Heading toward that red-letter date of November 5, OUTFRONT Media (NYSE: OUT) has got its ducks in a row. They're ready to spill the beans on third-quarter numbers after close of market—just as clocks hit 4:30 p.m. Eastern. It’s showtime, folks. What’s at Stake? We're talking OUTFRONT Media—one of the big kahunas in out-of-home...

Continue Reading
Fresenius Revamps U.S. Kidney Care with multiFiltratePRO

Updated Category News Views 2

Fresenius Takes a Giant Leap in Kidney Care Fresenius Medical Care is breaking new ground in the U.S., marking a significant milestone with the introduction of the multiFiltratePRO System for critically ill patients battling acute kidney injury (AKI). This isn't some run-of-the-mill equipment upgrade. It's an evolution in how critical care teams manage continuous kidney...

Continue Reading
Eightpoint Backs Community Shelter with Vital Aid

Updated Category News Views 2

Eightpoint Technologies Steps Up for a Crucial Cause Kicking in when it counts, Eightpoint Technologies has done something that might not turn stock market heads but speaks volumes about corporate responsibility. They're ponying up for a year's worth of groceries for the Cayman Islands Crisis Centre (CICC) starting November 1, 2026. We're talking real relief for women and...

Continue Reading
Pediatric Dental Visits: Setting the Stage Early Matters

Updated Category News Views 1

Unlocking the Secrets of First Dental Visits When should little ones start showing up in that dental chair? You might be thinking, "I'll wait until they actually have a full set of chompers," but that's a rookie move, folks. A piece coming out of HelloNation suggests parents hustle those kiddos into the dentist's office by their first birthday or six months after the...

Continue Reading
Direct Digital's Bold Exit: Delists from Nasdaq

Updated Category News Views 2

Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...

Continue Reading
PrimoHoagies Expanding: New Franchisees and Big Moves

Updated Category News Views 3

Fresh Bites of Opportunity at PrimoHoagies Head down to Philly and you'll catch wind of a tasty venture cooking up some buzz: PrimoHoagies is diving into 2026 with seven fresh franchisees under their wing. What you've got here isn't some scrappy startup grasping at straws, but a solid name packing over three decades under its belt. When experienced restaurant operators...

Continue Reading
Labcorp Scoops Up BioReference Health For $722M+

Updated Category News Views 2

Picture this: You’re a big fish like Labcorp ready to feast on smaller catches. That’s exactly what’s rolling out as OPKO Health cuts a deal to offload a chunk of its BioReference Health assets to Labcorp for a tidy $722 million in cash. Assets on the Move OPKO’s BioReference Health has long been a player in the clinical testing world, with a focus on services...

Continue Reading
Liver Disease Summit Fosters Awareness and Community

Updated Category News Views 7

Gathering for a Greater Cause in Chicago The American Liver Foundation (ALF) hosted a summit in the Windy City that was as much about heart as it was about livers. This wasn’t just another sterile conference; it was a grassroots rally for those battling metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease...

Continue Reading
Samsung Biologics' Big Gains and Ambitious Moves in 2026

Updated Category News Views 9

A Robust Third Quarter Samsung Biologics is making some serious noise in the biopharma sector with its latest Q3 2026 financial results. We're talking about KRW 1,490 billion in revenue, an uptick that screams growth, backed by an operating profit of KRW 640 billion. What's fueling this engine? Their relentless plant expansion and a pivotal step into the U.S. market....

Continue Reading
Glint: Lovense's New Era in Intimacy Tech

Updated Category News Views 7

From Thrill to Touch: The Glint Debut Screw the traditional remote control for sex toys! Lovense is straight up flipping the script with Glint. This isn't about adding more buttons or connecting another app. We're talking about a butt plug that lets your partner's thrust set the whole vibe. Forget fumbling with phones in the heat of the moment—this toy syncs your...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Growth of $100 Invested in KKR Over a Decade

Updated Category News Views 137

The Remarkable Growth of KKR Over the Past Decade Investing in KKR (NYSE: KKR) ten years ago would have been a smart move for any investor. Throughout this decade, KKR has consistently outperformed market expectations, achieving an impressive annualized return of 19.49%. This standout performance exceeds the market average by 8.29%, highlighting the potential of strategic...

Continue Reading
Therap Services Launches T-Log Module for Enhanced Communication

Updated Category News Views 233

Enhancing Communication with Therap's T-Log Module Therap Services, a prominent player in the realm of HIPAA-compliant electronic documentation solutions, is committed to empowering agencies within the Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS), and various other human services sectors. With the introduction of its innovative T-Log...

Continue Reading
BioMarin Secures $850 Million in Senior Notes for Growth Strategy

Updated Category News Views 98

BioMarin Unveils New Funding Strategy for Expansion BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) recently announced its successful pricing of a significant offering of $850 million in senior unsecured notes, due 2034. These notes carry a fixed interest rate of 5.500%, with an issue price set at 100.000%. The anticipated closing date for this offering is just around the...

Continue Reading
Piramal Pharma Limited's Financial Highlights for Q3 FY25

Updated Category News Views 388

Piramal Pharma Limited Financial Results Overview Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635) has announced compelling results for the third quarter (Q3) and the first nine months (9M) of FY25, highlighting a strong performance in the pharmaceutical and wellness sectors. Consolidated Financial Highlights The company reported significant financial metrics, with...

Continue Reading
Five Star Development Navigates Chapter 11 for Project Completion

Updated Category News Views 368

Five Star Development Takes Steps for Project Protection Five Star Development, LLC, alongside affiliated entities, has recently announced its decision to file for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court. This pivotal move aims to ensure that the ambitious project known as The Palmeraie, which includes The Ritz-Carlton Paradise Valley, can be...

Continue Reading